New-Born Screening Market Analysis
The global newborn screening market is predicted to grow at a 10.5% CAGR over the forecast period (2018-2023), states the latest Market Research Future (MRFR) report. Newborn screening, simply put, are medical tests, most of which are genetic, carried out for identifying babies having specific disorders that without intervention is likely to affect newborns as well as their families permanently.
Various factors are propelling the newborn screening market growth. Some of these factors, according to the Market Research Future report, include the rising base of neonatal population, favorable government policies, various technological advancements, and increasing government initiatives for research and development. Additional factors pushing market growth include growing demand for early disease detection tests, rising number of neonatal diseases including congenital hypothyroidism and newborn hearing loss, and rising cases of critical congenital heart defects.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/6561
On the contrary, absence of infrastructure, different socio-economic restraints, the high cost of automation technology, and lack of uniformity of newborn screening procedures and policies are factors that may restrict the newborn screening market growth over the forecast period.
The MRFR report offers a wide segmental analysis of the newborn screening market on the basis of end users, product, test type, and technology.
Based on technology, the newborn screening market is segmented into pulse oximetry screening technology, hearing screening technology, DNA-based assays, enzymatic assays, immunoassays, electrophoresis, and tandem mass spectrometry (TMS).
Based on test type, the newborn screening market is segmented into urine test, critical congenital heart diseases (CCHD) tests, hearing screening test, and dry blood spot test. Of these, the dry blood spot test segment will have the largest share in the market over the forecast period.
Based on products, the newborn screening market is segmented into assay kits and instruments and reagents. The instruments segment is further segmented into pulse oximeters, newborn hearing screening instruments, ultrasound machine, retinoscope, laparoscope, and mass spectrometer. The newborn screening segment is further segmented into hearing screening accessories and hearing screening devices. Of these, the mass spectrometer segment will dominate the market over the forecast period. This is owing to its increasing function to diagnose different conditions in one procedure.
Based on end users, the newborn screening market is segmented into diagnostic centers, maternity and specialty clinics, hospitals, and others. Of these, hospitals will lead the market over the forecast period.
Based on region, the newborn screening market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. This is owing to medical tourism, technological advancements, and rising healthcare awareness.
The newborn screening market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to growing government funding for newborn screening.
The newborn screening market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to favorable healthcare schemes that are drafted by government agencies, quality assurance, and awareness programs of newborn diagnostic procedures. Sri Lanka, China, Taiwan, and Korea are the key contributors in the region.
The newborn screening market in the MEA is predicted to have minimal share over the forecast period. This is owing to low per capita income and strict government policies.
Leading players profiled in the newborn screening market report include ZenTech S.A, Trivitron Healthcare, GE Healthcare (A Subsidiary of General Electric Company), Covidien PLC, Bio-Rad Laboratories, Inc., Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Waters Corporation, Perkinelmer, Inc., and AB Sciex LLC (A Subsidiary of Danaher Corporation).
August 2019: The Winconsin State Laboratory of Hygiene is utilizing the technology of Quantabio for improving newborn/neonatal screening of SMA (spinal muscular atrophy) and SCID (severe combined immunodeficiency). This laboratory is creating a cost-effective, easier, and faster way of simultaneously screening both the conditions.
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/new-born-screening-market-6561
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.